U.S. markets close in 2 hours 58 minutes
  • S&P 500

    4,293.77
    +13.62 (+0.32%)
     
  • Dow 30

    33,928.89
    +167.84 (+0.50%)
     
  • Nasdaq

    13,102.68
    +55.49 (+0.43%)
     
  • Russell 2000

    2,011.82
    -4.80 (-0.24%)
     
  • Crude Oil

    89.19
    -2.90 (-3.15%)
     
  • Gold

    1,797.00
    -18.50 (-1.02%)
     
  • Silver

    20.31
    -0.39 (-1.90%)
     
  • EUR/USD

    1.0177
    -0.0080 (-0.78%)
     
  • 10-Yr Bond

    2.7810
    -0.0680 (-2.39%)
     
  • GBP/USD

    1.2084
    -0.0055 (-0.45%)
     
  • USD/JPY

    133.1720
    -0.3080 (-0.23%)
     
  • BTC-USD

    24,258.92
    -78.09 (-0.32%)
     
  • CMC Crypto 200

    577.56
    -13.20 (-2.23%)
     
  • FTSE 100

    7,509.15
    +8.26 (+0.11%)
     
  • Nikkei 225

    28,871.78
    +324.80 (+1.14%)
     

MedAvail to Report 2022 Second Quarter Financial Results on August 11, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

MISSISSAUGA, Ontario & PHOENIX, July 28, 2022--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced it will report financial results for the second quarter of 2022 on Thursday, August 11, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the "Investor Relations" section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

About SpotRx

SpotRx places control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability.

SOURCE MedAvail Holdings, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005184/en/

Contacts

Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com